Skip To Main Content
Kitt Sinden on Muck Rack

Kitt Sinden

Toronto
As seen in: Mondaq
Partner and Patent Agent at Aird & McBurney LP in Toronto in the pharma, biotech, chemical and medical device fields.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kitt

Contact Kitt, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Important New Procedural Guidelines From The PMPRB

|
By Kaitlin Soye, Kitt Sinden
| Mondaq
The Patented Medicine Prices Review Board (PMPRB) is a Canadian federal agency that regulates the prices of patented medicines in Canada. The PMPRB is established and empowered under the federal jurisdiction over patents in subsection 91(22) of the Constitution Act, 1867. Under sections 79-83 of the Patent Act, the PMPRB makes sure that the exclusivity granted by patents for medicines in Canada is not abused.
Open in Who Shared Issue with article?

The Quiet Arrival of Patent Term Adjustment in Canada

|
By Kitt Sinden
| airdberlis.com
On January 1, 2025, Canada implemented a patent term adjustment (“PTA”) system to account for unreasonable delays by the Canadian Intellectual Property Office (“CIPO”) in issuing a patent. The PTA system has been enacted for compliance with Canada’s obligations under the Canada-United States-Mexico Agreement.
Open in Who Shared Issue with article?

Patent Term Adjustment Is Coming To Canada But Very Few Patents Will Qualify

|
By Kitt Sinden
| Mondaq
As explained in our previous article, in order to comply with Canada's obligations under the Canada-United States-Mexico Agreement ("CUSMA"), Canada agreed to implement a patent term adjustment ("PTA") framework to compensate patentees for unreasonable delays by the Canadian Patent Office ("Patent Office") in the granting of their patents.
Open in Who Shared Issue with article?
See all 8 articles